×

Rhetoric risk in biotech will continue: Pro

4:02 PM ET Mon, 28 Sept 2015

Ron Muhlenkamp, Muhlenkamp Fund founder and portfolio manager, provides perspective on where to invest and the current state of the U.S. economy.